The DOI matches its Crossref record; 289 of the 291 references it cites were found in a registry or an index.
HCN Channel Targets for Novel Antidepressant Treatment
Open accessAbstract
Major depressive disorder (MDD) is a chronic and potentially life threatening illness that carries a staggering global burden. Characterized by depressed mood, MDD is often difficult to diagnose and treat owing to heterogeneity of syndrome and complex etiology. Contemporary antidepressant treatments are based on improved monoamine-based formulations from serendipitous discoveries made > 60 years ago. Novel antidepressant treatments are necessary, as roughly half of patients using available antidepressants do not see long-term remission of depressive symptoms. Current development of treatment options focuses on generating efficacious antidepressants, identifying depression-related neural substrates, and better understanding the pathophysiological mechanisms of depression. Recent insight into the brain's mesocorticolimbic circuitry from animal models of depression underscores the importance of ionic mechanisms in neuronal homeostasis and dysregulation, and substantial evidence highlights a potential role for ion channels in mediating depression-related excitability changes. In particular, hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are essential regulators of neuronal excitability. In this review, we describe seminal research on HCN channels in the prefrontal cortex and hippocampus in stress and depression-related behaviors, and highlight substantial evidence within the ventral tegmental area supporting the development of novel therapeutics targeting HCN channels in MDD. We argue that methods targeting the activity of reward-related brain areas have significant potential as superior treatments for depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Available evidence suggests a plausible HCN-linked phenotype involving cognitive inertia and slowed affective transitions, but this remains a translational hypothesis rather than a validated treatment mechanism [290,291].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [290]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“meta-analytic datasets suggest comparable efficacy to several standard treatments when dose and resistance are considered, with emerging hints of cognitive improvement alongside mood change [290]”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [290]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Clinically, dorsolateral prefrontal transcranial direct current stimulation (tDCS) yields the largest benefits in patients with psychomotor retardation and executive disturbance”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [290]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
A neural substrate of prediction and reward
Schultz, W., Dayan, P., & Montague, P. R. (1997) · Science · doi:10.1126/science.275.5306.1593 · Cited by 9,388
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,526
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Millisecond-timescale, genetically targeted optical control of neural activity
Boyden, E. S., Zhang, F., Bamberg, E., Nagel, G., & Deisseroth, K. A. (2005) · Nature Neuroscience · doi:10.1038/nn1525 · Cited by 5,015
Depression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
Schildkraut, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,568
The tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Stress signalling pathways that impair prefrontal cortex structure and function
Arnsten, A. F. T. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2648 · Cited by 3,299
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307 · cited 6×
“We found that CSDS increased the Ih current in susceptible animals, and that HCN channels play a role in the pathophysiological increase in firing rate characteristic of susceptibility [43].”
BackgroundInfluentialSelf-citationEssential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
THE EFFECTS OF STRESSFUL LIFE EVENTS ON DEPRESSION
Kessler, R. C. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.191 · Cited by 2,111 · cited 1×
“Notably, prolonged stress is thought to catalyze the onset and/ or recurrence of depression [28].”
BackgroundThe mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Animal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926
Willner, P. (1997) · Psychopharmacology · doi:10.1007/s002130050456 · Cited by 1,832
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Willner, P. (2005) · Neuropsychobiology · doi:10.1159/000087097 · Cited by 1,605
Limbic-cortical dysregulation: a proposed model of depression
(1997) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.9.3.471 · Cited by 1,585
A standardized protocol for repeated social defeat stress in mice
Golden, S. A., Covington, H. E., Berton, O., & Russo, S. J. (2011) · Nature Protocols · doi:10.1038/nprot.2011.361 · Cited by 1,581
Diagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380
Two types of dopamine neuron distinctly convey positive and negative motivational signals
Matsumoto, M., & Hikosaka, O. (2009) · Nature · doi:10.1038/nature08028 · Cited by 1,378
KCNQ2 and KCNQ3 Potassium Channel Subunits: Molecular Correlates of the M-Channel
Wang, H. (1998) · Science · doi:10.1126/science.282.5395.1890 · Cited by 1,294
Psychobiology and molecular genetics of resilience
Feder, A., Nestler, E. J., & Charney, D. S. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2649 · Cited by 1,272
Russo, S. J., Murrough, J. W., Han, M.-H., Charney, D. S., & Nestler, E. J. (2012) · Nature Neuroscience · doi:10.1038/nn.3234 · Cited by 1,206
Self-citationThe cellular neurobiology of depression
Manji, H. K., Drevets, W. C., & Charney, D. S. (2001) · Nature Medicine · doi:10.1038/87865 · Cited by 1,182
Hyperpolarization-Activated Cation Currents: From Molecules to Physiological Function
Robinson, R. B., & Siegelbaum, S. A. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142734 · Cited by 1,177
Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication
Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J.-F., & Young, L. T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01083-6 · Cited by 1,164
Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons
Chaudhury, D., Walsh, J. J., Friedman, A. K., Juarez, B., Ku, S. M., Koo, J. W., Ferguson, D., Tsai, H.-C., Pomeranz, L., Christoffel, D. J., et al. (2013) · Nature · doi:10.1038/nature11713 · Cited by 1,156
Self-citationLower Hippocampal Volume in Patients Suffering From Depression: A Meta-Analysis
Campbell, S., Marriott, M., Nahmias, C., & MacQueen, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.598 · Cited by 1,156
Mayberg, H. S., Brannan, S. K., Tekell, J. L., Silva, J. A., Mahurin, R. K., McGinnis, S., & Jerabek, P. A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01036-2 · Cited by 1,115
Abercrombie, E. D., Keefe, K. A., DiFrischia, D. S., & Zigmond, M. J. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09224.x · Cited by 1,106
Dopamine neurons modulate neural encoding and expression of depression-related behaviour
Tye, K. M., Mirzabekov, J. J., Warden, M. R., Ferenczi, E. A., Tsai, H.-C., Finkelstein, J., Kim, S.-Y., Adhikari, A., Thompson, K. R., Andalman, A. S., et al. (2013) · Nature · doi:10.1038/nature11740 · Cited by 1,073
Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0203 · Cited by 1,054
Regulation of firing of dopaminergic neurons and control of goal-directed behaviors
Grace, A. A., Floresco, S. B., Goto, Y., & Lodge, D. J. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.003 · Cited by 1,034
Selective activation of the mesocortical DA system by stress
Thierry, A. M., Tassin, J., BLANC, G., & Glowinski, J. (1976) · Nature · doi:10.1038/263242a0 · Cited by 1,033
Schultz, W. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.007 · Cited by 1,028
Deep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression
Schlaepfer, T. E., Cohen, M. X., Frick, C., Kosel, M., Brodesser, D., Axmacher, N., Joe, A. Y., Kreft, M., Lenartz, D., & Sturm, V. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301408 · Cited by 1,027
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory
Vijayraghavan, S., Wang, M., Birnbaum, S. G., Williams, G. V., & Arnsten, A. F. T. (2007) · Nature Neuroscience · doi:10.1038/nn1846 · Cited by 1,013
Magee, J. C. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-19-07613.1998 · Cited by 981
Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system
Lammel, S., Hetzel, A., Häckel, O., Jones, I., Liss, B., & Roeper, J. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.022 · Cited by 976
A family of hyperpolarization-activated mammalian cation channels
Ludwig, A., Zong, X., Jeglitsch, M., Hofmann, F. B., & Biel, M. (1998) · Nature · doi:10.1038/31255 · Cited by 944
A meta‐analytic study of changes in brain activation in depression
Fitzgerald, P. B., Laird, A. R., Maller, J., & Daskalakis, Z. J. (2008) · Human Brain Mapping · doi:10.1002/hbm.20426 · Cited by 903
The role of the hippocampus in the pathophysiology of major depression
Campbell, S., & MacQUEEN, G. M. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0441 · Cited by 891
Multiple recurrences of major depressive disorder
Solomon, D. A., Keller, M. B., Leon, A. C., Mueller, T. I., Lavori, P. W., Shea, M. T., Coryell, W., Warshaw, M., Turvey, C., Maser, J. D., et al. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.2.229 · Cited by 835
Voltage-gated potassium channels as therapeutic targets
Wulff, H., Castle, N. A., & Pardo, L. A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2983 · Cited by 810
Lucki, I. (1997) · Behavioural Pharmacology · doi:10.1097/00008877-199711000-00010 · Cited by 803
Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli
Brischoux, F., Chakraborty, S., Brierley, D. I., & Ungless, M. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811507106 · Cited by 801
Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment
Warner‐Schmidt, J. L., & Duman, R. S. (2006) · Hippocampus · doi:10.1002/hipo.20156 · Cited by 787
Stress weakens prefrontal networks: molecular insults to higher cognition
Arnsten, A. F. T. (2015) · Nature Neuroscience · doi:10.1038/nn.4087 · Cited by 752 · cited 2×
“Chronic stress is extensively damaging to the cognitive center of the brain, affecting working memory, regulation of information processing, and error computation [111, 112].”
BackgroundDendritic integration of excitatory synaptic input
Magee, J. C. (2000) · Nature reviews. Neuroscience · doi:10.1038/35044552 · Cited by 737
Kennedy, S. H., Evans, K. R., Krüger, S., Mayberg, H. S., Meyer, J. H., McCann, S., Arifuzzman, A. I., Houle, S., & Vaccarino, F. J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.899 · Cited by 710
Pathways modulating neural KCNQ/M (Kv7) potassium channels
Delmas, P., & Brown, D. A. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1785 · Cited by 686
Essential role of brain-derived neurotrophic factor in adult hippocampal function
Monteggia, L. M., Barrot, M., Powell, C. M., Berton, O., Galanis, V., Gemelli, T., Meuth, S., Nagy, A., Greene, R. W., & Nestler, E. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402141101 · Cited by 685
Channelrhodopsin-2 and optical control of excitable cells
Zhang, F., Wang, L., Boyden, E. S., & Deisseroth, K. A. (2006) · Nature Methods · doi:10.1038/nmeth936 · Cited by 683
Wang, M., Ramos, B. P., Paspalas, C. D., Shu, Y., Simen, A., Duque, A., Vijayraghavan, S., Brennan, A., Dudley, A., Nou, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.015 · Cited by 672
Too many cooks? Intrinsic and synaptic homeostatic mechanisms in cortical circuit refinement
Turrigiano, G. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153238 · Cited by 671
Synaptic potentiation onto habenula neurons in the learned helplessness model of depression
Li, B., Piriz, J., Mirrione, M., Chung, C., Proulx, C. D., Schulz, D., Henn, F., & Malinow, R. (2011) · Nature · doi:10.1038/nature09742 · Cited by 634
Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex
Covington, H. E., Lobo, M. K., Maze, I., Vialou, V., Hyman, J. M., Zaman, S., LaPlant, Q., Mouzon, E., Ghose, S., Tamminga, C. A., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1731-10.2010 · Cited by 621
Dendritic Ih normalizes temporal summation in hippocampal CA1 neurons
Magee, J. C. (1999) · Nature Neuroscience · doi:10.1038/9158 · Cited by 617
Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression.
Newport, D. J., Carpenter, L. L., McDonald, W. M., Potash, J. B., Tohen, M., Nemeroff, C. B., & The APA Council of Research Task Force on Novel Biomarkers and Treatments (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040465 · Cited by 598
Immunohistochemical localization of Ih channel subunits, HCN1–4, in the rat brain
Notomi, T., & Shigemoto, R. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.11039 · Cited by 558
Signaling pathways underlying the rapid antidepressant actions of ketamine
Duman, R. S., Li, N., Liu, R.-J., Duric, V., & Aghajanian, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.044 · Cited by 537
Drug addiction: A model for the molecular basis of neural plasticity
Nestler, E. J., Hope, B. T., & Widnell, K. L. (1993) · Neuron · doi:10.1016/0896-6273(93)90213-b · Cited by 535
Margolis, E. B., Lock, H., Hjelmstad, G. O., & Fields, H. L. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.117069 · Cited by 527
The neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519
Monteggia, L. M., Luikart, B., Barrot, M., Theobold, D., Malkovska, I., Nef, S., Parada, L. F., & Nestler, E. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.021 · Cited by 502
Tidey, J. W., & Miczek, K. A. (1996) · Brain Research · doi:10.1016/0006-8993(96)00159-x · Cited by 496
Ventral hippocampal afferents to the nucleus accumbens regulate susceptibility to depression
Bagot, R. C., Parise, E. M., Peña, C. J., Zhang, H.-X., Maze, I., Chaudhury, D., Persaud, B., Cachope, R., Bolaños-Guzmán, C. A., Cheer, J. F., et al. (2015) · Nature Communications · doi:10.1038/ncomms8062 · Cited by 491
Self-citationA Behavioral Role for Dendritic Integration
Nolan, M. F., Malleret, G., Dudman, J. T., Buhl, D. L., Santoro, B., Gibbs, E., Vronskaya, S., Buzsáki, G., Siegelbaum, S. A., Kandel, E. R., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.020 · Cited by 487
Neuronal basis of age-related working memory decline
Wang, M., Gamo, N. J., Yang, Y., Jin, L. E., Wang, X.-J., Laubach, M., Mazer, J. A., Lee, D., & Arnsten, A. F. T. (2011) · Nature · doi:10.1038/nature10243 · Cited by 485
Enhancing depression mechanisms in midbrain dopamine neurons achieves homeostatic resilience
Friedman, A. K., Walsh, J. J., Juarez, B., Ku, S. M., Chaudhury, D., Wang, J., Li, X., Dietz, D. M., Pan, N., Vialou, V. F., et al. (2014) · Science · doi:10.1126/science.1249240 · Cited by 484
Self-citationTargeting glutamate signalling in depression: progress and prospects
Murrough, J. W., Abdallah, C. G., & Mathew, S. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.16 · Cited by 482
ΔFosB in brain reward circuits mediates resilience to stress and antidepressant responses
Vialou, V., Robison, A. J., LaPlant, Q. C., Covington, H. E., Dietz, D. M., Ohnishi, Y. N., Mouzon, E., Rush, A. J., Watts, E. L., Wallace, D. L., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2551 · Cited by 479
Role of Corticotropin-Releasing Factor in Drug Addiction
Logrip, M. L., Koob, G. F., & Zorrilla, E. P. (2011) · CNS Drugs · doi:10.2165/11587790-000000000-00000 · Cited by 474
Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites
Poolos, N. P., Migliore, M., & Johnston, D. (2002) · Nature Neuroscience · doi:10.1038/nn891 · Cited by 454
Polarized and compartment-dependent distribution of HCN1 in pyramidal cell dendrites
Lőrincz, A., Notomi, T., Tamás, G., Shigemoto, R., & Nusser, Z. (2002) · Nature Neuroscience · doi:10.1038/nn962 · Cited by 452
Are you or aren’t you? Challenges associated with physiologically identifying dopamine neurons
Ungless, M. A., & Grace, A. A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.02.003 · Cited by 450
HCN channels: Structure, cellular regulation and physiological function
Wahl‐Schott, C., & Biel, M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8525-0 · Cited by 448
A Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders
Frye, M. A., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Speer, A. M., Osuch, E. A., Luckenbaugh, D. A., Corá-Locatelli, G., Leverich, G. S., & Post, R. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00004 · Cited by 446
Geddes, J. R., Calabrese, J. R., & Goodwin, G. M. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.048504 · Cited by 433
Eisch, A. J., Bolaños, C. A., de Wit, J., Simonak, R. D., Pudiak, C. M., Barrot, M., Verhaagen, J., & Nestler, E. J. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.003 · Cited by 420
Furey, M. L., & Drevets, W. C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1121 · Cited by 417
Chen, S., Wang, J., & Siegelbaum, S. A. (2001) · The Journal of General Physiology · doi:10.1085/jgp.117.5.491 · Cited by 416
Moosmang, S., Stieber, J., Zong, X., Biel, M., Hofmann, F. B., & Ludwig, A. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02036.x · Cited by 415
Hu, H., Vervaeke, K., & Storm, J. F. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.029249 · Cited by 410
Lacey, M. G., Mercuri, N. B., & North, R. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-04-01233.1989 · Cited by 406
Tatulian, L., Delmas, P., Abogadie, F. C., & Brown, D. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05535.2001 · Cited by 406
Stress: metaplastic effects in the hippocampus
Kim, J. J., & Yoon, K. S. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01322-8 · Cited by 403
Cao, J.-L., Covington, H. E., Friedman, A. K., Wilkinson, M. B., Walsh, J. J., Cooper, D. C., Nestler, E. J., & Han, M.-H. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3177-10.2010 · Cited by 402
Self-citationNeuhoff, H., Neu, A. D., Liss, B., & Roeper, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-04-01290.2002 · Cited by 400
Activity-dependent decrease of excitability in rat hippocampal neurons through increases in Ih
Fan, Y., Fricker, D., Brager, D. H., Chen, X., Lu, H., Chitwood, R. A., & Johnston, D. (2005) · Nature Neuroscience · doi:10.1038/nn1568 · Cited by 397
Hodes, G. E., Pfau, M. L., Purushothaman, I., Ahn, H. F., Golden, S. A., Christoffel, D. J., Magida, J., Brancato, A., Takahashi, A., Flanigan, M. E., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1392-15.2015 · Cited by 395
Treatment of Social Phobia With Gabapentin
Pande, A. C., Davidson, J. R. T., Jefferson, J. W., Janney, C. A., Katzelnick, D. J., Weisler, R. H., Greist, J. H., & Sutherland, S. M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199908000-00010 · Cited by 394
Sallee, F. R., Mcgough, J., Wigal, T., Donahue, J., Lyne, A., & Biederman, J. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318191769e · Cited by 391
Ethanol Directly Excites Dopaminergic Ventral Tegmental Area Reward Neurons
Brodie, M. S., Pesold, C., & Appel, S. B. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04082.x · Cited by 388
The Role of Corticotropin-Releasing Factor in Drug Addiction
Sarnyai, Z., Shaham, Y., & Heinrichs, S. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01492-3 · Cited by 381
Adachi, M., Barrot, M., Autry, A. E., Theobald, D., & Monteggia, L. M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.019 · Cited by 380
Gu, N., Vervaeke, K., Hu, H., & Storm, J. F. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.086835 · Cited by 363
Neurophysiology of HCN channels: From cellular functions to multiple regulations
He, C., Chen, F., Li, B., & Hu, Z. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.10.001 · Cited by 363
HCN2 Ion Channels Play a Central Role in Inflammatory and Neuropathic Pain
Emery, E. C., Young, G. T., Berrocoso, E., Chen, L., & McNaughton, P. A. (2011) · Science · doi:10.1126/science.1206243 · Cited by 353
Hauger, R., Risbrough, V. B., Brauns, O., & Dautzenberg, F. M. (2006) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152706777950684 · Cited by 344
Depression, antidepressants, and the shrinking hippocampus
Sapolsky, R. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231475998 · Cited by 341
Physiology and pharmacology of the cardiac pacemaker (“funny”) current
Baruscotti, M., Bucchi, A., & DiFrancesco, D. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.01.005 · Cited by 338
Structural and synaptic plasticity in stress-related disorders
Christoffel, D. J., Golden, S. A., & Russo, S. J. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.044 · Cited by 334
Antidepressants and gabapentinoids in neuropathic pain: Mechanistic insights
Kremer, M., Salvat, É., Muller, A., Yalçın, İ., & Barrot, M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.057 · Cited by 333
Biederman, J., Melmed, R. D., Patel, A., McBurnett, K., Konow, J., Lyne, A., Scherer, N., & for the SPD503 Study Group (2008) · Pediatrics · doi:10.1542/peds.2006-3695 · Cited by 317
Gabapentin in bipolar disorder: a placebo‐controlled trial of adjunctive therapy1
Pande, A. C., Crockatt, J. G., Janney, C. A., Werth, J. L., Tsaroucha, G., & Gabapentin Bipolar Disorder Study Group (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.20305.x · Cited by 314
Goldman-Rakic, P. S., Lidow, M. S., & Gallager, D. W. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-07-02125.1990 · Cited by 311
Resilience to Chronic Stress Is Mediated by Hippocampal Brain-Derived Neurotrophic Factor
Taliaz, D., Loya, A., Gersner, R., Haramati, S., Chen, A., & Zangen, A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5725-10.2011 · Cited by 311
Dopaminergic Innervation of the Amygdala Is Highly Responsive to Stress
Inglis, F., & Moghaddam, B. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721088.x · Cited by 310
Harris, N. C., & Constanti, A. (1995) · Journal of Neurophysiology · doi:10.1152/jn.1995.74.6.2366 · Cited by 298
Amygdala Modulation of Multiple Memory Systems: Hippocampus and Caudate-Putamen
Packard, M. G., & Teather, L. A. (1998) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1997.3815 · Cited by 287
Birnbaum, S., Gobeske, K. T., Auerbach, J., Taylor, J. R., & Arnsten, A. F. T. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00138-9 · Cited by 281
HCN1 Channel Subunits Are a Molecular Substrate for Hypnotic Actions of Ketamine
Chen, X., Shu, S., & Bayliss, D. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3481-08.2009 · Cited by 278
Epigenetic Mechanisms of Depression and Antidepressant Action
Vialou, V., Feng, J., Robison, A. J., & Nestler, E. J. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134540 · Cited by 277
Placebo-Controlled Study of Gabapentin Treatment of Panic Disorder
Pande, A. C., Pollack, M. H., Crockatt, J. G., Greiner, M., Chouinard, G., Lydiard, R. B., Taylor, C. B., Dager, S. R., & Shiovitz, T. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00011 · Cited by 276
Stress models of depression: forming genetically vulnerable strains
Henn, F. A., & Vollmayr, B. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.019 · Cited by 274
Nolan, M. F., Malleret, G., Dudman, J. T., Buhl, D. L., Santoro, B., GIBBS, E., Vronskaya, S., Buzsáki, G., Siegelbaum, S. A., & Kandel, E. R. (2004) · Cell · doi:10.1016/s0092-8674(04)01055-4 · Cited by 274
A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder
Hertzberg, M. A., Butterfield, M. I., Feldman, M. E., Beckham, J. C., Sutherland, S. M., Connor, K. M., & Davidson, J. R. T. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00011-6 · Cited by 271
IκB Kinase Regulates Social Defeat Stress-Induced Synaptic and Behavioral Plasticity
Christoffel, D. J., Golden, S. A., Dumitriu, D., Robison, A. J., Janssen, W. G., Ahn, H. F., Krishnan, V., Reyes, C. M., Han, M.-H., Ables, J. L., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4763-10.2011 · Cited by 267
Self-citationVoleti, B., Navarria, A., Liu, R.-J., Banasr, M., Li, N., Terwilliger, R., Sanacora, G., Eid, T., Aghajanian, G., & Duman, R. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.04.025 · Cited by 264
Wilkinson, M. B., Xiao, G., Kumar, A., LaPlant, Q., Renthal, W., Sikder, D., Kodadek, T. J., & Nestler, E. J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0932-09.2009 · Cited by 262
Narayanan, R., & Johnston, D. (2007) · Neuron · doi:10.1016/j.neuron.2007.10.033 · Cited by 262
Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity
Gerhard, D. M., Wohleb, E. S., & Duman, R. S. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.016 · Cited by 261
Stahl, S. M. (1998) · PubMed · Cited by 260
Synaptic Mechanisms Underlying Rapid Antidepressant Action of Ketamine
Kavalali, E. T., & Monteggia, L. M. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12040531 · Cited by 258
Wanat, M. J., Hopf, F. W., Stuber, G. D., Phillips, P. E. M., & Bonci, A. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.150078 · Cited by 256
Neuronal plasticity and antidepressant actions
Castrén, E., & Hen, R. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.12.010 · Cited by 243
Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression
van der Loos, M. L. M., Mulder, P. G. H., Hartong, E. G. T. M., Blom, M. B. J., Vergouwen, A. C. M., de Keyzer, H. J. U. E. M., Notten, P., Luteijn, M. L., Timmermans, M. A. Y., Vieta, E., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04152 · Cited by 243
Delvecchio, G., Fossati, P., Boyer, P., Brambilla, P., Falkai, P., Gruber, O., Hietala, J. A., Lawrie, S. M., Martinot, J., McIntosh, A. M., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.003 · Cited by 234
Monteggia, L. M., Eisch, A. J., Tang, M. D., Kaczmarek, L. K., & Nestler, E. J. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00155-8 · Cited by 232
Enhancement of synaptic transmission by cyclic AMP modulation of presynaptic Ih channels
Beaumont, V., & Zucker, R. S. (2000) · Nature Neuroscience · doi:10.1038/72072 · Cited by 226
HCN1 Channels Constrain Synaptically Evoked Ca2+ Spikes in Distal Dendrites of CA1 Pyramidal Neurons
Tsay, D., Dudman, J. T., & Siegelbaum, S. A. (2007) · Neuron · doi:10.1016/j.neuron.2007.11.015 · Cited by 222
Exploring HCN channels as novel drug targets
Postea, O., & Biel, M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3576 · Cited by 222
Functional Heteromerization of HCN1 and HCN2 Pacemaker Channels
Ulens, C., & Tytgat, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000738200 · Cited by 217
Anand, A., Li, Y., Wang, Y., Gardner, K., & Lowe, M. J. (2007) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.19.3.274 · Cited by 215
Stress and CRF gate neural activation of BDNF in the mesolimbic reward pathway
Walsh, J. J., Friedman, A. K., Sun, H., Heller, E. A., Ku, S. M., Juarez, B., Burnham, V. L., Mazei-Robison, M. S., Ferguson, D., Golden, S. A., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3591 · Cited by 210
Self-citationArnsten, A. F. T. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm033 · Cited by 200
Assessing the role of Ih channels in synaptic transmission and mossy fiber LTP
Chevaleyre, V., & Castillo, P. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142213199 · Cited by 199
An update on regional brain volume differences associated with mood disorders
Campbell, S., & MacQueen, G. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000194371.47685.f2 · Cited by 198
Okamoto, T., Harnett, M. T., & Morikawa, H. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00682.2005 · Cited by 197
Nolan, M. F., Dudman, J. T., Dodson, P. D., & Santoro, B. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2358-07.2007 · Cited by 195
Antidepressant Effects of the Muscarinic Cholinergic Receptor Antagonist Scopolamine: A Review
Drevets, W. C., Zarate, C. A., & Furey, M. L. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.031 · Cited by 195
Tiihonen, J., Wahlbeck, K., & Kiviniemi, V. J. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.01.002 · Cited by 194
Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial
Tiihonen, J., Hallikainen, T., Ryynänen, O., Repo‐Tiihonen, E., Kotilainen, I., Eronen, M., Toivonen, P., Wahlbeck, K., & Putkonen, A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00524-9 · Cited by 191
George, M. S., Abbott, L. F., & Siegelbaum, S. A. (2009) · Nature Neuroscience · doi:10.1038/nn.2307 · Cited by 187
Tritt, K., Nickel, C., Lahmann, C., Leiberich, P. K., Rother, W. K., Loew, T. H., & Nickel, M. K. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105051540 · Cited by 186
Neural Substrates of Depression and Resilience
Han, M., & Nestler, E. J. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0527-x · Cited by 185
Self-citationBrower, K. J., Kim, H. M., Strobbe, S., Karam‐Hage, M., Consens, F. B., & Zucker, R. A. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00706.x · Cited by 181
Krishnan, V., Han, M.-H., Mazei-Robison, M., Iñiguez, S. D., Ables, J. L., Vialou, V., Berton, O., Ghose, S., Covington, H. E., Wiley, M. D., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.003 · Cited by 176
Self-citationProperties of ivabradine‐induced block of HCN1 and HCN4 pacemaker channels
Bucchi, A., Tognati, A., Milanesi, R., Baruscotti, M., & DiFrancesco, D. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.100776 · Cited by 175
Bagot, R. C., Cates, H. M., Purushothaman, I., Vialou, V., Heller, E. A., Yieh, L., Labonté, B., Peña, C. J., Shen, L., Wittenberg, G. M., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.06.012 · Cited by 175
Day, M., Carr, D. B., Ulrich, S., Ilijić, E., Tkatch, T., & Surmeier, D. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2650-05.2005 · Cited by 173
Diversity of Dopaminergic Neural Circuits in Response to Drug Exposure
Juarez, B., & Han, M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.32 · Cited by 173
Self-citationAn Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs
Jacob, S., & Nair, A. B. (2016) · Drugs in R&D · doi:10.1007/s40268-016-0148-6 · Cited by 173
KCNQ channel openers reverse depressive symptoms via an active resilience mechanism
Friedman, A. K., Juarez, B., Ku, S. M., Zhang, H., Calizo, R. C., Walsh, J. J., Chaudhury, D., Zhang, S., Hawkins, A., Dietz, D. M., et al. (2016) · Nature Communications · doi:10.1038/ncomms11671 · Cited by 172
Self-citationNarayanan, R., & Johnston, D. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0835-08.2008 · Cited by 171
Hernández, C. C., Zaika, O., Tolstykh, G. P., & Shapiro, M. S. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.148304 · Cited by 170
Peripheral and central mechanisms of stress resilience
Pfau, M. L., & Russo, S. J. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2014.09.004 · Cited by 170
Bipolar Disorder — A Focus on Depression
Frye, M. A. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp1000402 · Cited by 170
Spectrum of Activity of Lamotrigine in Treatment-Refractory Bipolar Disorder
Calabrese, J. R., Bowden, C. L., McElroy, S. L., Cookson, J., Andersen, J., Keck, P. E., Rhodes, L. J., Watson, C. B., Zhou, J. J., & Ascher, J. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1019 · Cited by 167
Santoro, B., Piskorowski, R. A., Pian, P., Hu, L., Liu, H., & Siegelbaum, S. A. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.009 · Cited by 164
Gabapentin as a Potential Treatment for Anxiety Disorders
Pollack, M. H., Matthews, J., & Scott, E. L. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.7.992 · Cited by 159
Kim, C. S., Chang, P. Y., & Johnston, D. (2012) · Neuron · doi:10.1016/j.neuron.2012.05.027 · Cited by 158
Mediation of Hippocampal Mossy Fiber Long-Term Potentiation by Presynaptic I h Channels
Mellor, J. R., Nicoll, R. A., & Schmitz, D. (2002) · Science · doi:10.1126/science.1064285 · Cited by 158
The Anticonvulsant Lamotrigine in Treatment-Resistant Manic-Depressive Illness
Sporn, J., & Sachs, G. S. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199706000-00008 · Cited by 155
Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine
Wohleb, E. S., Gerhard, D. M., Thomas, A., & Duman, R. S. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160309114549 · Cited by 151
Alternatively Spliced Isoforms of TRIP8b Differentially Control h Channel Trafficking and Function
Lewis, A. S., Schwartz, E., Chan, C. S., Noam, Y., Shin, M., Wadman, W. J., Surmeier, D. J., Baram, T. Z., Macdonald, R. L., & Chetkovich, D. M. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0856-09.2009 · Cited by 150
Gabapentin in PTSD: A Retrospective, Clinical Series of Adjunctive Therapy1
Hamner, M. B., Brodrick, P. S., & Labbate, L. A. (2001) · Annals of Clinical Psychiatry · doi:10.1023/a:1012281424057 · Cited by 144
Franz, O., Liss, B., Neu, A. D., & Roeper, J. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00151.x · Cited by 140
The efficacy of lamotrigine in rapid cycling and non–rapid cycling patients with bipolar disorder
Bowden, C. L., Calabrese, J. R., McElroy, S. L., Rhodes, L. J., Keck, P. E., Cookson, J., Anderson, J., Watson, C. B., Ascher, J. A., Monaghan, E., et al. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00013-x · Cited by 139
Savelieva, I., & Camm, A. J. (2008) · Drug Safety · doi:10.2165/00002018-200831020-00001 · Cited by 139
Paspalas, C. D., Wang, M., & Arnsten, A. F. T. (2013) · Cerebral Cortex · doi:10.1093/cercor/bhs152 · Cited by 136
Anxiolytic Effects of Maxipost (BMS-204352) and Retigabine via Activation of Neuronal Kv7 Channels
Korsgaard, M. P. G., Hartz, B. P., Brown, W. D., Ahring, P. K., Strøbæk, D., & Mirza, N. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.083923 · Cited by 132
Antiglutamatergic Strategies for Ethanol Detoxification: Comparison With Placebo and Diazepam
Krupitsky, E. M., Rudenko, A. A., Burakov, A. M., Slavina, T. Y., Grinenko, A. Y., Pittman, B. P., Gueorguieva, R. V., Petrakis, I. L., Zvartau, E. E., & Krystal, J. H. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00344.x · Cited by 130
Towards an integrated view of HCN channel role in epilepsy
Noam, Y., Bernard, C., & Baram, T. Z. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.06.013 · Cited by 130
Lewis, A. S., Vaidya, S. P., Blaiss, C. A., Liu, Z., Stoub, T. R., Brager, D. H., Chen, X., Bender, R. A., Estep, C. M., Popov, A. B., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0936-11.2011 · Cited by 129
Voltage-Gated Ion Channels in the PNS: Novel Therapies for Neuropathic Pain?
Tibbs, G. R., Posson, D. J., & Goldstein, P. A. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.05.002 · Cited by 122
Pinto, O., & Akiskal, H. S. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00007-5 · Cited by 120
Ethanol Inhibits Persistent Activity in Prefrontal Cortical Neurons
Tu, Y., Kroener, S., Abernathy, K., Lapish, C. C., Seamans, J. K., Chandler, L. J., & Woodward, J. J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5378-06.2007 · Cited by 120
An open study of lamotrigine in refractory bipolar depression
Kusumakar, V., & Yatham, L. N. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(97)00082-6 · Cited by 119
Potential Mechanisms of Action of Lamotrigine in the Treatment of Bipolar Disorders
Ketter, T. A., Manji, H. K., & Post, R. M. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000088915.02635.e8 · Cited by 117
Gabapentin Increases the Hyperpolarization‐activated Cation Current Ih in Rat CA1 Pyramidal Cells
Surges, R., Freiman, T. M., & Feuerstein, T. J. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.36802.x · Cited by 117
The heterogeneity of ventral tegmental area neurons: Projection functions in a mood-related context
Walsh, J. J., & Han, M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.06.006 · Cited by 108
Self-citationGabapentin in PTSD: A Retrospective, Clinical Series of Adjunctive Therapy1
Hamner, M. B., Brodrick, P. S., & Labbate, L. A. (2001) · Annals of Clinical Psychiatry · doi:10.3109/10401230109148960 · Cited by 106
Robison, A. J., Vialou, V., Sun, H.-S., Labonte, B., A Golden, S., Dias, C., Turecki, G., Tamminga, C., Russo, S., Mazei-Robison, M., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.319 · Cited by 105
α2δ and the mechanism of action of gabapentin in the treatment of pain
Maneuf, Y. P., Luo, Z. D., & Lee, K. (2006) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2006.09.003 · Cited by 105
Coderre, T. J., Kumar, N., Lefebvre, C. D., & Yu, J. S. C. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04304.x · Cited by 103
Hopf, F. W., Martín, M., Chen, B. T., Bowers, M. S., Mohamedi, M. L., & Bonci, A. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00824.2007 · Cited by 103
Bruno, A., Micò, U., Pandolfo, G., Mallamace, D., Abenavoli, E., Di Nardo, F., D’Arrigo, C., Spina, E., Zoccali, R. A., & Muscatello, M. R. A. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111431751 · Cited by 103
Baruscotti, M., Bottelli, G., Milanesi, R., DiFrancesco, J. C., & DiFrancesco, D. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0810-8 · Cited by 100
Research works printed but not linked: 1
- Brannon, 2000, Gabapentin treatment for posttraumatic stress disorder, Can J Psychiatry., 45, 84
Cited by
Sorted by citations
Neurobiology of Resilience: Interface Between Mind and Body
Cathomas, F., Murrough, J. W., Nestler, E. J., Han, M.-H., & Russo, S. J. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.011 · Cited by 296
“It is known that RSDS increases the excitatory Ih current in VTA DA neurons of susceptible mice, and induces even greater increases in Ih in these neurons of resilient mice (51) (53) (54).”
BackgroundSelf-citationRole of Mesolimbic Brain-Derived Neurotrophic Factor in Depression
Koo, J. W., Chaudhury, D., Han, M.-H., & Nestler, E. J. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.020 · Cited by 112
Self-citationSantoro, B., & Shah, M. M. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023356 · Cited by 108
HCN2 channels in the ventral tegmental area regulate behavioral responses to chronic stress
Zhong, P., Vickstrom, C. R., Liu, X., Hu, Y., Yu, L., Yu, H.-G., & Liu, Q.-S. (2018) · eLife · doi:10.7554/elife.32420 · Cited by 99
“…CMS reduced action potential (AP) firing in VTA dopamine neurons (Chang and Grace, 2014; Moreines et al., 2017; Tye et al., 2013), whereas susceptibility to CSDS was accompanied by an increase in AP firing (Cao et al., 2010; Chaudhury et al., 2013; Krishnan et al., 2007; Ku and Han, 2017).”
BackgroundUnderstanding Lamotrigine’s Role in the CNS and Possible Future Evolution
Costa, B., & Vale, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076050 · Cited by 79
Metadata
- Authors
- Ku, S. M., & Han, M.-H.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Han, Ming-Hu
- ORCID
- Han, Ming-Hu
- Venue
- Neurotherapeutics
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 14
- Issue
- 3
- Pages
- 698-715
- ISSN
- 1878-7479 (ISSN-L)
- PMC
- PMC5509632
- OpenAlex
- W2619412584
- Cited by
- 54
- References
- 291
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 9 · 2023: 9 · 2022: 4 · 2021: 5 · 2020: 9 · 2019: 4 · 2018: 4 · 2017: 2
- FWCI
- 0.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Neurotherapeutics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R21MH112081, F31MH108326)
- Brain and Behavior Research Foundation (NARSAD)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- HCN channels, major depressive disorder, antidepressant drug development, neuronal excitability, mesocorticolimbic circuitry, prefrontal cortex, hippocampus, ventral tegmental area, stress
- MeSH terms
- Animals, Antidepressive Agents, Brain, Major Depressive Disorder, Humans, Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review